Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis

Table 2

Quality assessment of included studies based on the Newcastle-Ottawa scales.

Name	A	B	C	D	E	F	G	H	Scroe
Mohri et al. [18]									7
Jiang et al. [13]									8
Cho et al. [20]									7
Graziosi et al. [19]									7
Aurello et al. [21]									5
El Aziz [22]									6
Lee et al. [23]									4
Lee et al. [24]									3
Jin et al. [25]									6
Dirican et al. [26]									6
Wang et al. [14]									8
Kunisaki et al. [27]									6
Kim and Choi [28]									5
Jeong et al. [29]									8
Jung et al. [30]									6
Ubukata et al. [31]									7
Shimada et al. [32]									7
Mohri et al. [33]									6
Yamanaka et al. [34]									5

A: representativeness of the exposed cohort; B: selection of the nonexposed cohort; C: ascertainment of exposure; D: demonstration that outcome of interest was not present at start of study; E: comparability of cohorts on the basis of the design or analysis; F: assessment of outcome; G: follow-up long enough for outcomes to occur; H: adequacy of follow-up of cohorts.